Italia markets open in 2 hours 18 minutes

Dow Jones
37.775,38
+22,07(+0,06%)
Nasdaq
15.601,50
-81,87(-0,52%)
Nikkei 225
37.162,97
-916,73(-2,41%)
EUR/USD
1,0642
-0,0005(-0,04%)
Bitcoin EUR
58.884,99
+664,66(+1,14%)
CMC Crypto 200
1.286,04
+400,50(+43,97%)

UCB SA (0NZT.IL)

IOB - IOB Prezzo differito. Valuta in EUR.

Aggiungi a watchlist

120,10

+0,40

(+0,33%)

Alla chiusura: 06:45PM BST

Capitalizzazione	24,437B
Beta (5 anni mensile)	0,34
Rapporto PE (ttm)	70,65
EPS (ttm)	1,70
Prossima data utili	N/D
Rendimento e dividendo (futuro)	1,33 (1,84%)
Data ex dividendo	28 apr 2023
Stima target 1A	N/D

Tutte

GlobeNewswire
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has entered into a multi-year license agreement with UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical leader, to partner on drug delivery platforms for UCB’s gene therapy portfolio. “We are extremely excited to partner with UCB, a global biopharmaceutical leader, with a focus on inno